Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Ventyx Biosciences (VTYX) Stock Forecast & Price Target

Ventyx Biosciences logo
Get the Latest News and Ratings for VTYX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Ventyx Biosciences and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VTYX Analyst Ratings Over Time

TypeCurrent Forecast
5/9/25 to 5/9/26
1 Month Ago
4/9/25 to 4/9/26
3 Months Ago
2/8/25 to 2/8/26
1 Year Ago
5/9/24 to 5/9/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
3 Buy rating(s)
Hold
8 Hold rating(s)
8 Hold rating(s)
8 Hold rating(s)
1 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$14.00$14.00$14.00$10.00
Forecasted UpsideN/AN/A0.29% Upside706.45% Upside
Consensus RatingReduceReduceReduceModerate Buy

VTYX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

VTYX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Ventyx Biosciences Stock vs. The Competition

TypeVentyx BiosciencesMedical CompaniesS&P 500
Consensus Rating Score
1.89
2.30
2.52
Consensus RatingReduceHoldModerate Buy
Predicted UpsideN/A858.42% Upside15.52% Upside
News Sentiment Rating
Neutral News

See Recent VTYX News
Neutral News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
1/8/2026
Piper Sandler logo
Piper Sandler
2 of 5 stars
 DowngradeOverweightHold$14.00+1.56%
1/8/2026
Oppenheimer Holdings, Inc. logo
Oppenheimer
3 of 5 stars
Jeff Jones
Jeff Jones
5 of 5 stars
DowngradeOutperformMarket Perform
1/8/2026
HC Wainwright logo
HC Wainwright
3 of 5 stars
Emily Bodnar
Emily Bodnar
4 of 5 stars
DowngradeBuyNeutral$14.00+1.97%
1/8/2026Reiterated RatingBuyNeutral$20.00 ➝ $14.00+1.97%
1/8/2026DowngradeBuyHold$16.00 ➝ $14.00+1.97%
1/8/2026Reiterated RatingOverweightEqual Weight$14.00+1.56%
1/8/2026Reiterated RatingOutperformMarket Perform$14.00+1.97%
1/7/2026 DowngradeStrong-BuyHold
10/8/2025 Reiterated RatingSell (D-)

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 07:33 AM ET.


VTYX Forecast - Frequently Asked Questions

According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Ventyx Biosciences is $14.00, with a high forecast of $14.00 and a low forecast of $14.00.

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ventyx Biosciences in the last twelve months. There is currently 1 sell rating and 8 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" VTYX shares.

Analysts like Ventyx Biosciences less than other "medical" companies. The consensus rating for Ventyx Biosciences is Reduce while the average consensus rating for "medical" companies is Hold. Learn more on how VTYX compares to other companies.


This page (NASDAQ:VTYX) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners